Lithium Ion

Lithium Ion

SCHEMBL7702608

CN(CC(=O)[O-])C[C@H]1CCc2c(F)cccc2[C@H]1c1ccccc1.[Li+]

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 2/20 0.52
MTNR1A P48039 2/20 0.42
MTNR1B P49286 2/20 0.42
TRPM8 Q7Z2W7 1/20 0.36
SIGMAR1 Q99720 2/20 0.34
DRD2 P14416 2/20 0.34
DRD3 P35462 2/20 0.34
TACR1 P25103 1/20 0.34
BLM P54132 1/20 0.34
TSHR P16473 1/20 0.34
HTR6 P50406 1/20 0.34
DRD5 P21918 2/20 0.33
KDM4C Q9H3R0 2/20 0.33
KDM4A O75164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL7703444 0.83 SLC6A9 (0.62) SLC6A9MTNR1AMTNR1BSIGMAR1TACR1
Lithium Ion SCHEMBL7698448 0.81 SLC6A9 (0.54) SLC6A9MTNR1AMTNR1BTRPM8SIGMAR1
Lithium Ion SCHEMBL7704198 0.81 SLC6A9 (0.51) SLC6A9MTNR1AMTNR1BSIGMAR1BLM
Lithium Ion SCHEMBL7702844 0.80 SLC6A9 (0.63) SLC6A9MTNR1AMTNR1BSIGMAR1TACR1
Lithium Ion SCHEMBL7702768 0.80 SLC6A9 (0.60) SLC6A9MTNR1AMTNR1BTACR1
Lithium Ion SCHEMBL7698462 0.78 SLC6A9 (0.69) SLC6A9MTNR1AMTNR1BTRPM8TACR1
Org-25935 SCHEMBL7704305 0.78 SLC6A9 (0.85) SLC6A9MTNR1AMTNR1B
Org-25935 SCHEMBL7703028 0.78 SLC6A9 (0.85) SLC6A9MTNR1AMTNR1B
Lithium Ion SCHEMBL7700187 0.77 SLC6A9 (0.70) SLC6A9MTNR1AMTNR1BKDM4C
Lithium Ion SCHEMBL7698371 0.77 SLC6A9 (0.53) SLC6A9MTNR1AMTNR1BHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100769-B1 AMINOMETHYLCARBOXYLIC ACID DERIVATIVES AKZO NOBEL NV (NL) 2002-12-04 EP disclosed
US-6410592-B1 THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS AKZO NOBEL N.V. (NL) 2002-06-25 US disclosed